Tuesday, July 21, 2009

Canadian scientists are using novel technology to decode the DNA of cancer

A team of researchers in Canada has made a breakthrough discovery that could lead to many new cancer diagnostics and treatments. They discovered that a single genetic mutation leads to granulosa cell tumors, a rare form of ovarian cancer.

This is truly remarkable when you consider that there are three billion components in the genetic code of a the tumor. The research published recently in the New England Journal of Medicine, could be a major breakthrough, because the same state-of-the-art technology used to identify the mutation in ovarian cancer's DNA can also be used to decode the genetic sequences of other cancers. 

It is believed that this technology will pave the way for personalized medicine. By being able to decide the genetic sequences of specific cancers, doctors will be able to subscribe customized medicines for each patient. This could enable the most effective treatment for each individual with the least side effects.

While these developments are very exciting, much work remains to be done in order for personalized medicine to become a reality. But thanks to this amazing breakthrough, we are now one step closer.